350 research outputs found
High mobility dry-transferred CVD bilayer graphene
We report on the fabrication and characterization of high-quality chemical
vapor-deposited (CVD) bilayer graphene (BLG). In particular, we demonstrate
that CVD-grown BLG can mechanically be detached from the copper foil by an
hexagonal boron nitride (hBN) crystal after oxidation of the copper-to-BLG
interface. Confocal Raman spectroscopy reveals an AB-stacking order of the BLG
crystals and a high structural quality. From transport measurements on fully
encapsulated hBN/BLG/hBN Hall bar devices we extract charge carrier mobilities
up to 180,000 cm/(Vs) at 2 K and up to 40,000 cm/(Vs) at 300 K,
outperforming state-of-the-art CVD bilayer graphene devices. Moreover, we show
an on-off ration of more than 10,000 and a band gap opening with values of up
to 15 meV for a displacement field of 0.2 V/nm in such CVD grown BLG.Comment: 5 pages, 4 figure
The present state of surface conditioning in cutting and grinding
All manufacturing processes have an impact on the surface layer state of a component, which in turn significantly determines the properties of parts in service. Although these effects should certainly be exploited, knowledge on the conditioning of the surfaces during the final cutting and abrasive process of metal components is still only extremely limited today. The key challenges in regard comprise the process-oriented acquisition of suitable measurement signals and their use in robust process control with regard to the surface layer conditions. By mastering these challenges, the present demands for sustainability in production on the one hand and the material requirements in terms of lightweight construction strength on the other hand can be successfully met. In this review article completely new surface conditioning approaches are presented, which originate from the Priority Program 2086 of the Deutsche Forschungsgemeinschaft (DFG)
Material parameter optimization for orthogonal cutting simulations of AISI4140 at various tempering conditions
The mechanical parameters of quenched and tempered AISI4140 and the machining process characteristics are depending on the materialâs tempering state. The process characteristics of practical relevance are not only the cutting forces and the tool wear, but also the surface layer states of the machined part. In order to predict and to improve these characteristics efficiently, chip forming simulation via finite element method (FEM) is commonly applied. However, an issue in machining simulation which is often addressed is choosing appropriate material parameters for the flow stress model. This especially accounts for AISI4140 with various tempering conditions, as in many cases the precise heat treatment is not supplied in detail, even in scientific literature.
In this work, orthogonal cutting of AISI4140 with tempering temperatures of 300°C, 450°C and 600°C is investigated by experiments and FE simulations. The Johnson-Cook flow stress model is used in the FE simulation. The referring material parameters for the tempering conditions are iteratively adapted via numerical optimization to fit experimental cutting forces. The obtained parameters are compared to literature values in order to prepare a common ground for the cutting simulation of AISI4140. This contributes to an enhanced process modelling when machining AISI4140 with use-case adapted heat treatments
Raman spectroscopy as probe of nanometer-scale strain variations in graphene
Confocal Raman spectroscopy is a versatile, non-invasive investigation tool
and a major workhorse for graphene characterization. Here we show that the
experimentally observed Raman 2D line width is a measure of nanometer-scale
strain variations in graphene. By investigating the relation between the G and
2D line at high magnetic fields we find that the 2D line width contains
valuable information on nanometer-scale flatness and lattice deformations of
graphene, making it a good quantity for classifying the structural quality of
graphene even at zero magnetic field.Comment: 7 pages, 4 figure
VRG Program Evaluation 2021. Self-Evaluation Report by the WWTF Office
Dieser Selbstevaluationsbericht enthĂ€lt Informationen ĂŒber das VRG-Programm. Er dient als Input fĂŒr die 2021 stattfindende Evaluierung des WWTF-Programms "Vienna Research Groups for Young Investigators" (VRG) durch ein internationales Gutachtergremium. Das VRG-Programm wurde
wird seit 2010 von der Stadt Wien finanziert und vom Wiener Wissenschafts- und Technologiefonds (WWTF) umgesetzt
Modeling of surface hardening and roughness induced by turning AISI 4140 QT under different machining conditions
Two Patterns of Adipokine and Other Biomarker Dynamics in a Long-Term Weight Loss Intervention
Objective: Long-term dietary intervention frequently induces a rapid weight decline followed by weight stabilization/regain. Here, we sought to identify adipokine biomarkers that may reflect continued beneficial effects of dieting despite partial weight regain. Research design and methods: We analyzed the dynamics of fasting serum levels of 12 traditional metabolic biomarkers and novel adipokines among 322 participants in the 2-year Dietary Intervention Randomized Controlled Trial (DIRECT) of low-fat, Mediterranean, or low-carbohydrate diets for weight loss. Results: We identified two distinct patterns: Pattern A includes biomarkers (insulin, triglycerides, leptin, chemerin, monocyte chemoattractant protein 1, and retinol-binding protein 4) whose dynamics tightly correspond to changes in body weight, with the trend during the weight loss phase (months 0â6) going in the opposite direction to that in the weight maintenance/regain phase (months 7â24) (P < 0.05 between phases, all biomarkers). Pattern B includes biomarkers (high molecular weight adiponectin, HDL cholesterol [HDL-C], high-sensitivity C-reactive protein [hsCRP], fetuin-A, progranulin, and vaspin) that displayed a continued, cumulative improvement (P < 0.05 compared with baseline, all biomarkers) throughout the intervention. These patterns were consistent across sex, diabetic groups, and diet groups, although the magnitude of change varied. Hierarchical analysis suggested similar clusters, revealing that the dynamic of leptin (pattern A) was most closely linked to weight change and that the dynamic of hsCRP best typified pattern B. Conclusions: hsCRP, HDL-C, adiponectin, fetuin-A, progranulin, and vaspin levels display a continued long-term improvement despite partial weight regain. This may likely reflect either a delayed effect of the initial weight loss or a continuous beneficial response to switching to healthier dietary patterns
Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer
Laboratory evidence suggests that vitamin D might influence prostate cancer prognosis.We examined the associations between prediagnostic plasma levels of 25(OH)vitamin D [25(OH)D] and 1,25(OH)(2) vitamin D [1,25(OH)(2)D] and mortality among 1822 participants of the Health Professionals Follow-up Study and Physicians' Health Study who were diagnosed with prostate cancer. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of total mortality (nâ=â595) and lethal prostate cancer (death from prostate cancer or development of bone metastases; nâ=â202). In models adjusted for age at diagnosis, BMI, physical activity, and smoking, we observed a HR of 1.22 (95% CI: 0.97, 1.54) for total mortality, comparing men in the lowest to the highest quartile of 25(OH)D. There was no association between 1,25(OH)(2)D and total mortality. Men with the lowest 25(OH)D quartile were more likely to die of their cancer (HR: 1.59; 95% CI: 1.06, 2.39) compared to those in the highest quartile (P(trend)â=â0.006). This association was largely explained by the association between low 25(OH)D levels and advanced cancer stage and higher Gleason score, suggesting that these variables may mediate the influence of 25(OH)D on prognosis. The association also tended to be stronger among patients with samples collected within five years of cancer diagnosis. 1,25(OH)(2)D levels were not associated with lethal prostate cancer.Although potential bias of less advanced disease due to more screening activity among men with high 25(OH)D levels cannot be ruled out, higher prediagnostic plasma 25(OH)D might be associated with improved prostate cancer prognosis
Recommended from our members
Renal Function Following Three Distinct Weight Loss Dietary Strategies During 2 Years of a Randomized Controlled Trial
OBJECTIVE This study addressed the long-term effect of various diets, particularly low-carbohydrate high-protein, on renal function on participants with or without type 2 diabetes. RESEARCH DESIGN AND METHODS In the 2-year Dietary Intervention Randomized Controlled Trial (DIRECT), 318 participants (age, 51 years; 86% men; BMI, 31 kg/m2; mean estimated glomerular filtration rate [eGFR], 70.5 mL/min/1.73 m2; mean urine microalbumin-to-creatinine ratio, 12:12) with serum creatinine 0.05) across diet groups. The increased eGFR was at least as prominent in participants with (+6.7%) or without (+4.5%) type 2 diabetes or those with lower baseline renal function of eGFR <60 mL/min/1.73 m2 (+7.1%) versus eGFR â„60 mL/min/1.73 m2 (+3.7%). In a multivariable model adjusted for age, sex, diet group, type 2 diabetes, use of ACE inhibitors, 2-year weight loss, and change in protein intake (confounders and univariate predictors), only a decrease in fasting insulin (ÎČ = â0.211; P = 0.004) and systolic blood pressure (ÎČ = â0.25; P < 0.001) were independently associated with increased eGFR. The urine microalbumin-to-creatinine ratio improved similarly across the diets, particularly among participants with baseline sex-adjusted microalbuminuria, with a mean change of â24.8 (P < 0.05). CONCLUSIONS A low-carbohydrate diet is as safe as Mediterranean or low-fat diets in preserving/improving renal function among moderately obese participants with or without type 2 diabetes, with baseline serum creatinine <176 ÎŒmol/L. Potential improvement is likely to be mediated by weight lossâinduced improvements in insulin sensitivity and blood pressure
The Effect of Weight-Loss Interventions on Cervical and Chin Subcutaneous Fat Depots; the CENTRAL Randomized Controlled Trial
Accumulation of cervical and chin subcutaneous adipose tissues (SAT) represent known phenotypes of obesity. We aimed to evaluate the sensitivity of these fat storages to long-term weight-loss directed lifestyle-intervention and to assess their relations to bodily-adiposity, insulin-resistance, and cardiometabolic risk; We randomly assigned 278 participants with abdominal-obesity/dyslipidemia to low-fat or Mediterranean/low-carbohydrate diets +/â physical-activity. All participants underwent an 18 month whole-body magnetic resonance imaging follow-up, from which we assessed cervical and chin SAT-areas; Participants (age = 48 years; 90% men; body-mass-index = 30.9 kg/m2) had an 18-month adherence-rate of 86%. Cervical-SAT and chin-SAT decreased after 6-months (â13.1% and â5.3%, respectively, p < 0.001). After 18-months only cervical-SAT remained decreased compared to baseline (â5%, p < 0.001). Cervical and chin-SAT 18-month changes were associated with changes in weight (r = 0.70, r = 0.66 respectively; <0.001 for both) and visceral-adipose-tissue (VAT; r = 0.35, r = 0.42 respectively; <0.001 for both). After adjustment to VAT, waist-circumference, or weight-changes, chin-SAT 18-month reduction was associated with favorable changes in fasting-glucose (ÎČ = 0.10; p = 0.05), HbA1c (ÎČ = 0.12; p = 0.03), and homeostasis-model-assessment-of-insulin-resistance (ÎČ = 0.12; p = 0.03). Cervical-SAT 18-month reduction was associated with decreased triglycerides (ÎČ = 0.16; p = 0.02) and leptin (ÎČ = 0.19; p = 0.01) independent of VAT; Cervical and chin-SATs are dynamic fat depots that correspond with weight-loss and are associated with changes in cardiometabolic profile. In long-term, chin-SAT displays a larger rebound compared with cervical-SAT. Chin-SAT accumulation is associated with in insulin-resistance, independent of central obesity. (ClinicalTrials identifier NCT01530724
- âŠ